Investment Management Corp of Ontario

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1811568 Toronto, Z4

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,765,092

-$1,388,212 QoQ

Shares Held

7,642

-4.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#396

of 1,322 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Investment Management Corp of Ontario holds $37,554,611 across 7 Biotechnology names. REGN ranks #4 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	46,155	$13,894,039
2	VRTX	Vertex Pharmaceuticals Inc / Ma	16,215	$8,054,476
3	INCY	Incyte Corp	53,029	$6,011,367
4	REGN	Regeneron Pharmaceuticals, Inc. This page	7,642	$4,765,092
5	RVMD	Revolution Medicines, Inc.	10,300	$1,928,984
6	RPRX	Royalty Pharma plc	26,212	$1,469,706
7	INSM	INSMED Inc	13,421	$1,430,947

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,765,092	7,642	-4.0%	Shares	Sole	2026-08-14
2026-03-31	$6,153,304	7,964	-13.5%	Shares	Sole	2026-05-15
2025-12-31	$7,105,835	9,206	+28.6%	Shares	Sole	2026-02-17
2025-09-30	$4,023,604	7,156	+50.7%	Shares	Sole	2025-11-14
2025-06-30	$2,493,225	4,749	-9.5%	Shares	Sole	2025-08-14
2025-03-31	$3,329,073	5,249	+1.9%	Shares	Sole	2025-05-15
2024-12-31	$3,667,787	5,149	+43.5%	Shares	Sole	2025-02-14
2024-09-30	$3,770,797	3,587	+50.3%	Shares	Sole	2024-11-14
2024-06-30	$2,508,808	2,387	+41.5%	Shares	Sole	2024-08-14
2024-03-31	$1,623,720	1,687	-32.2%	Shares	Sole	2024-05-15
2023-12-31	$2,184,307	2,487	+73.4%	Shares	Sole	2024-02-14
2022-12-31	$1,034,616	1,434	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.